Setmelanotide (Imcivree®, Rhythm Pharmaceuticals, Inc., Boston, MA, USA) is a melanocortin-4 receptor (MC4R) agonist indicated only for the treatment of obesity caused by deficiency in MC4R signaling. This evidence concerns the gene MC4R and obesity disorder.